US EditionNew FDA restrictions will make COVID-19 vaccines only available to elderly and people with medical conditions
- Government advisers met on Thursday, May 28, 2025, to decide whether COVID-19 vaccines need updating for better fall and winter protection.
- This meeting follows the FDA's recent change limiting routine COVID-19 booster approval to seniors and high-risk younger people, ending universal annual boosters.
- The CDC's advisory panel will meet in June 2025 to recommend vaccination strategies, including options for universal access or targeted high-risk group vaccination.
- University of Minnesota expert Michael Osterholm said, "This is a mess," highlighting uncertainties about vaccine eligibility and insurer coverage for healthy lower-risk individuals.
- The new FDA approach, criticized for ending the U.S.'s "one-size-fits-all" booster policy, suggests significant implications for fall vaccination campaigns amid ongoing policy and strain-selection guidance needs.
438 Articles
438 Articles
Los Angeles Times
It is not clear what the next changes mean for people who may still want a vaccine against COVID-19 in the fall, but who do not fit clearly into one of the categories.
The EXPLOSION of myocarditis: Dr. Peter McCullough’s bombshell vaccine testimony
In a Senate hearing this week about the safety of the COVID-19 vaccine, Dr. Peter McCullough detailed his experience as a cardiologist — and after the shots, it’s not a good one. “The topic today is myocarditis or heart damage from the COVID-19 vaccines. I’m a cardiologist. I know the topic well...
FDA Orders COVID-19 Vaccine Makers to Expand Heart Inflammation Warning - News Addicts
The Food and Drug Administration has directed COVID-19 vaccine manufacturers to expand the warning for two forms of inflammation, according to letters made public on May 21. The FDA told BioNTech, which produces a vaccine with Pfizer, and Moderna to update warnings regarding myocarditis—or heart inflammation—and the related condition pericarditis. Richard Forshee, acting director of […] The post FDA Orders COVID-19 Vaccine Makers to Expand Heart…
The FDA has called on vaccine manufacturers Pfizer and Moderna to provide their Covid-19 gene syringes with much sharper warnings of possible heart damage. An analysis of the data from market surveillance shows that the risks to myocarditis and pericarditis are greater than originally assumed. The new findings again raise questions about the transparency and communication of the health authorities during the pandemic. The letters to both compani…
FDA Panel Split on COVID-19 Booster Update Amid Policy Confusion
Government advisers were split Thursday on whether drugmakers need to update their COVID-19 vaccines for next season, a decision overshadowed by confusion over a new Trump administration policy that may limit which Americans can get the shots. The Food and Drug Administration’s outside experts have met annually since the launch of the first COVID-19 vaccines to discuss tweaking their recipes to stay ahead of the virus. The challenge is trying to…
San Diego doctors react to new FDA guidelines on COVID-19 shots
SAN DIEGO (FOX 5/KUSI) — The U.S. Food and Drug Administration is implementing more rigorous standards for approving future COVD-19 vaccines. The agency is no longer recommending universal boosters for everyone 6 months or older and will now take a more targeted approach, limiting its availability to seniors and those with pre-existing conditions that put them at a high-risk for severe illness. These new guidelines were published Tuesday in the …
Coverage Details
Bias Distribution
- 65% of the sources are Center
To view factuality data please Upgrade to Premium
